Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Return on Assets (2022 - 2026)

Atara Biotherapeutics filings provide 5 years of Return on Assets readings, the most recent being 0.02% for Q1 2026.

  • On a quarterly basis, Return on Assets fell 2.0% to 0.02% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.02%, a 2.0% decrease, with the full-year FY2025 number at 0.0%, up 1.0% from a year prior.
  • Return on Assets hit 0.02% in Q1 2026 for Atara Biotherapeutics, down from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.01% in Q3 2025 to a low of 0.02% in Q1 2026.
  • Median Return on Assets over the past 5 years was 0.01% (2024), compared with a mean of 0.01%.
  • Biggest five-year swings in Return on Assets: rose 2bps in 2025 and later decreased -2bps in 2026.
  • Atara Biotherapeutics' Return on Assets stood at 0.01% in 2022, then tumbled by -154bps to 0.02% in 2023, then soared by 57bps to 0.01% in 2024, then surged by 100bps to 0.0% in 2025, then crashed by -107803bps to 0.02% in 2026.
  • The last three reported values for Return on Assets were 0.02% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025) per Business Quant data.